Cancer Research Institute CEO Alicia Zhou, PhD, traces her path from teenage lab technician to leader in cancer immunotherapy. Trained at MIT and Dana-Farber, she worked on The Cancer Genome Atlas before moving to industry at Color Genomics, expanding access to clinical sequencing. Zhou champions applying advanced genomics to immunotherapy through CRI’s Discovery Engine, an open dataset mapping tumor–immune interactions. She argues nonprofits uniquely fund shared infrastructure and standardization efforts. By supporting collaboration, young scientists, and patient resources, Zhou aims to accelerate breakthroughs and ultimately make cancer solvable.
Produced and hosted by Jonathan D. Grinstein, PhD
Audio mixed and mastered by Erick Ziegler
Brought to you by Inside Precision Medicine (SAGE Publishing)
Hosted on Acast. See acast.com/privacy for more information.
